Precision BioSciences Inc...

NASDAQ: DTIL · Real-Time Price · USD
4.71
-0.06 (-1.26%)
At close: Aug 15, 2025, 3:59 PM
4.71
-0.11%
After-hours: Aug 15, 2025, 07:51 PM EDT

Precision BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.26M 51.14M 68.7M 75.1M 87.64M 57.53M 48.73M 52.29M 46.53M 30.56M 25.1M 20.84M 37.51M 102.5M 115.53M 118.04M 101.36M 33.64M
Cost of Revenue
696K n/a n/a 1.56M 3.59M 5.98M 8.26M 8.97M 9.19M 9.03M 9M 6.73M 4.48M 2.26M n/a n/a n/a n/a
Gross Profit
565K 51.14M 68.7M 73.54M 84.05M 51.55M 40.47M 43.31M 37.34M 21.54M 16.09M 14.11M 33.03M 100.24M 115.53M 118.04M 101.36M 33.64M
Operating Income
-90.11M -44.09M -26.16M -16.21M -7.29M -43.43M -63.7M -69.36M -79.93M -97.54M -100.42M -110.63M -99.24M -48.01M -39.4M -32.13M -46.63M -101.07M
Interest Income
5.7M 6.42M 6.76M 7.1M 7.2M 7.31M 7.69M 7.8M 7.1M 5.34M 3.47M 1.6M 471K 327K 208K 172K 156K 215K
Pretax Income
-78.25M -21.99M 7.17M 11.48M 15.79M -28.85M -62.49M -77.55M -89.39M -108.53M -111.64M -105.44M -92.77M -40.08M -30.6M -31.77M -46.5M -100.86M
Net Income
-78.25M -21.99M 7.17M 8.62M 16.97M -27.67M -59.82M -80.02M -96.9M -117.48M -122.91M -108.71M -95.03M -40.9M -30.6M -31.77M -46.5M -100.86M
Selling & General & Admin
35.66M 35.42M 35.3M 34.26M 35.13M 36.43M 39.09M 40.62M 41.32M 41.98M 41.58M 42.13M 41.43M 40.89M 39.69M 38.27M 37.17M 35.94M
Research & Development
55.02M 59.8M 59.56M 57.04M 59.81M 64.53M 73.34M 81.03M 85.14M 86.13M 83.94M 89.34M 95.32M 109.62M 115.24M 111.89M 110.83M 98.78M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
90.67M 95.23M 94.86M 91.3M 94.93M 100.96M 112.43M 121.65M 126.46M 128.1M 125.52M 131.47M 136.75M 150.5M 154.93M 150.17M 148M 134.71M
Interest Expense
1.36M 1.56M 1.78M 1.97M 2.29M 2.28M 2.23M 2.14M 1.97M 1.59M 1.11M 678K 328K 174K 132K 79K 24K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
91.37M 95.23M 94.86M 91.3M 94.93M 100.96M 112.43M 121.65M 126.46M 128.1M 125.52M 131.47M 136.75M 150.5M 154.93M 150.17M 148M 134.71M
Income Tax Expense
n/a n/a n/a n/a n/a -3.2M -4.7M 3.3M 4.31M 8.95M 11.27M 3.33M 2.36M 978K 156K 130K 103K 162K
Shares Outstanding (Basic)
11.05M 929.21M 6.83M 7.29M 6.97M 5.06M 4.01M 3.84M 3.8M 3.71M 3.7M 3.69M 2.27M 2.03M 2.03M 1.99M 1.92M 1.89M
Shares Outstanding (Diluted)
11.05M 929.21M 6.88M 7.29M 7.01M 5.06M 4.01M 3.84M 3.8M 3.71M 3.7M 3.69M 2.27M 2.03M 2.03M 1.99M 1.99M 1.89M
EPS (Basic)
-6.91 -0.08 1.64 0.09 0.24 -7.59 -15.64 -21.45 -26.11 -37.31 -45.21 -46.32 -45.23 -19.65 -15.3 -17.72 -27 -57.15
EPS (Diluted)
-6.9 -0.1 1.62 0.06 0.21 -7.59 -15.64 -21.45 -26.11 -37.31 -45.21 -46.32 -45.23 -20.04 -15.69 -18.11 -27.39 -57.15
EBITDA
-73.73M -16.57M 13.53M 18.82M 24.48M -10.3M -43.15M -56.96M -68.76M -97.3M -100.91M -95.54M -82.89M -29.92M -20.27M -21.51M -36.38M -90.97M
EBIT
-76.89M -20.42M 8.95M 13.45M 18.08M -17.71M -51.41M -66.55M -78.56M -106.94M -110.53M -104.76M -92.44M -39.91M -30.47M -31.69M -46.48M -100.86M
Depreciation & Amortization
3.17M 3.85M 4.58M 5.38M 6.4M 7.4M 8.26M 8.97M 9.19M 9.03M 9M 9.22M 9.55M 9.99M 10.2M 10.17M 10.1M 9.89M